Why ResMed AirSense 11 quietly reshapes bedtime for sleep apnea patients

Reviewed: ad hoc news B2B & Pro desk. Edited and checked on 2026-06-20, 14:13. Details in the imprint.

ResMed AirSense 11 sits on the nightstand like a small matte-white monolith, its soft fan noise barely louder than a whisper while it pushes precisely metered air through the hose to keep a patient’s airway open.

What AirSense 11 is built to do

The AirSense 11 is ResMed’s current generation cloud-connected CPAP platform, designed for the long-haul treatment of obstructive sleep apnea at home. It replaces the widely used AirSense 10 line with more automation and tighter software integration.

On the outside it looks intentionally discreet, with rounded edges, a color touchscreen, and a side-loaded humidifier chamber that slides out like a drawer rather than a clunky tank to wrestle with every night.

Automation at bedtime

In use, the most noticeable feature is the optional AutoSet mode, which automatically adjusts pressure breath by breath to keep the airway open while avoiding the harsh blast many first-time CPAP users dread. Ramp and expiratory pressure relief soften the first minutes in bed so therapy feels less abrupt.

For patients who start therapy nervously, such smooth pressure transitions can be the difference between abandoning the mask after a week and sticking with the device for years.

Companion app and coaching

The AirSense 11 ties deeply into ResMed’s myAir smartphone app, which shows a nightly score based on usage hours, mask seal, events per hour, and mask-off incidents. A simple green-or-yellow dashboard gives an at-a-glance feeling of success or missed goals.

Short coaching tips pop up when the device detects recurring problems, such as high leak rates or frequent awakenings, turning abstract sleep data into practical instructions like tightening straps or adjusting bedtime routines.

Cloud data for clinicians

Behind the scenes, the AirSense 11 connects via cellular radio to ResMed’s AirView cloud platform, which allows sleep clinics and homecare providers to adjust pressure settings remotely and monitor adherence. That can save patients repeated in-person visits just for fine-tuning.

For B2B customers like durable medical equipment providers, this remote management is central to keeping therapy compliant with insurer rules while limiting costly truck rolls to patients’ homes.

Noise, comfort, and masks

Noise levels are low enough that in a quiet bedroom the soft rush of air tends to blend into background fan noise once the user wears the mask. The motor’s pitch is more of a steady hum than a high whine, which many patients perceive as calmer.

ResMed pairs the AirSense 11 with a broad mask ecosystem from nasal pillows to full-face models, so therapists can match breathing style and facial structure rather than forcing a one-mask-fits-all compromise.

Where it still annoys

The compact design means the integrated humidifier tank is relatively small, so in dry climates some users will find it runs low by early morning and needs careful fill discipline. The glossy top plate also shows dust and fingerprints quickly.

And while the touchscreen is responsive, it is tiny compared with a smartphone, so older users with impaired vision may still prefer to have their provider lock in settings and only glance at the big numeric pressure display.

Pricing and availability

In the United States, the AirSense 11 typically reaches patients via prescription through sleep clinics and durable medical equipment suppliers rather than direct retail, with payer-negotiated bundle pricing that wraps device, mask, and support together.

European availability depends on country-level distributors, but the device is broadly present in major markets via specialist respiratory care dealers rather than mainstream electronics chains.

How it fits ResMed’s strategy

Net-net, the AirSense 11 shows how ResMed leans hard into connected hardware plus recurring software and services, trading the old one-off box sale for a longer relationship with patients, providers, and payers.

ResMed Inc. (ISIN US7611521078) is listed on the New York Stock Exchange under the ticker RMD, where investors often read device updates like the AirSense 11 through the lens of long-term recurring therapy revenue.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.